Not applicableStudy completedNCT06630481
What this trial is testing
Long-term Survival Outcomes According to the Pathologic Response After Neoadjuvant Treatment in PDAC and the Fate of the Patients with Good CAP Grade
Who this might be right for
Pancreatic CancerNeoadjuvant TherapyPathological Complete Response
Seoul National University Hospital 462